- Home
- ESLA vs PIII Comparison
ESLA vs PIII Comparison
Compare ESLA & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESLA
- PIII
- Stock Information
- Founded
- ESLA 2021
- PIII 2015
- Country
- ESLA United States
- PIII United States
- Employees
- ESLA N/A
- PIII N/A
- Industry
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- PIII Medical/Nursing Services
- Sector
- ESLA Health Care
- PIII Health Care
- Exchange
- ESLA Nasdaq
- PIII Nasdaq
- Market Cap
- ESLA 35.5M
- PIII 30.8M
- IPO Year
- ESLA N/A
- PIII N/A
- Fundamental
- Price
- ESLA $1.07
- PIII $6.62
- Analyst Decision
- ESLA Strong Buy
- PIII Buy
- Analyst Count
- ESLA 1
- PIII 2
- Target Price
- ESLA $16.00
- PIII $16.25
- AVG Volume (30 Days)
- ESLA 518.6K
- PIII 5.1K
- Earning Date
- ESLA 06-17-2025
- PIII 05-15-2025
- Dividend Yield
- ESLA N/A
- PIII N/A
- EPS Growth
- ESLA N/A
- PIII N/A
- EPS
- ESLA N/A
- PIII N/A
- Revenue
- ESLA N/A
- PIII $1,485,192,000.00
- Revenue This Year
- ESLA $101.09
- PIII N/A
- Revenue Next Year
- ESLA N/A
- PIII $6.01
- P/E Ratio
- ESLA N/A
- PIII N/A
- Revenue Growth
- ESLA N/A
- PIII 9.79
- 52 Week Low
- ESLA $0.63
- PIII $6.47
- 52 Week High
- ESLA $3.23
- PIII $33.73
- Technical
- Relative Strength Index (RSI)
- ESLA 55.18
- PIII 30.04
- Support Level
- ESLA $0.78
- PIII $6.47
- Resistance Level
- ESLA $1.18
- PIII $7.45
- Average True Range (ATR)
- ESLA 0.10
- PIII 0.29
- MACD
- ESLA 0.00
- PIII -0.09
- Stochastic Oscillator
- ESLA 71.28
- PIII 8.26
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.